uniQure (QURE) Change in Cash (2016 - 2026)
uniQure (QURE) posted quarterly Change in Cash of $273.0 million for Q2 2026, up 645.68% year-over-year from $36.6 million in Q2 2025, and up 357.06% quarter-over-quarter from $59.7 million in Q1 2026.
Analysis
uniQure (QURE) Change in Cash (2016 - 2026) Analysis & Trends
uniQure's Change in Cash history runs 11 years deep, the most recent figure standing at $273.0 million for Q2 2026.
- In Q2 2026, Change in Cash rose 645.68% year-over-year to $273.0 million; the TTM figure through Jun 2026 stood at $159.3 million (up 545.35% YoY), while the FY2025 annual figure was -$78.5 million, up 6.75% from the prior year.
- Change in Cash for Q2 2026 stood at $273.0 million, up from $59.7 million in the prior quarter.
- The five-year high for Change in Cash was $359.7 million in Q2 2023, with the low at -$516.7 million in Q4 2025.
- The 5-year median for Change in Cash is -$11.4 million (2022), against an average of -$8.0 million.
- The sharpest annual moves came in 2024 and 2025: Change in Cash tumbled 878.89% in 2024, then surged 3361.66% in 2025.
- uniQure's Change in Cash stood at -$212.2 million in 2022, then jumped by 105.61% to $11.9 million in 2023, then sank by 878.89% to -$92.8 million in 2024, then slumped by 457.14% to -$516.7 million in 2025, then jumped by 152.84% to $273.0 million in 2026.
- Business Quant data shows QURE's Change in Cash at $273.0 million in Q2 2026, $59.7 million in Q1 2026, and -$516.7 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -185.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 374.50 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 427.25 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.94 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 225.59 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -37.42 Mn |
| 10 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | 273.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 273.03 Mn |
| Mar 31, 2026 | 59.74 Mn |
| Dec 31, 2025 | -516.75 Mn |
| Sep 30, 2025 | 343.28 Mn |
| Jun 30, 2025 | 36.61 Mn |
| Mar 31, 2025 | 58.33 Mn |
| Dec 31, 2024 | -92.75 Mn |
| Sep 30, 2024 | -37.96 Mn |
| Jun 30, 2024 | 44.81 Mn |
| Mar 31, 2024 | 1.69 Mn |
| Dec 31, 2023 | 11.91 Mn |
| Sep 30, 2023 | -284.14 Mn |
| Jun 30, 2023 | 359.75 Mn |
| Mar 31, 2023 | -74.15 Mn |
| Dec 31, 2022 | -212.25 Mn |
| Sep 30, 2022 | -60.25 Mn |
| Jun 30, 2022 | -24.41 Mn |
| Mar 31, 2022 | -31.27 Mn |
| Dec 31, 2021 | -21.92 Mn |
| Sep 30, 2021 | -98.89 Mn |